NPPB and heart failure: In addition, the GUIDing Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) trial showed that patients with NT-pro BNP declines of ≤1,000 pg/ml during the application of guideline-directed medical therapy (GDMT) have better outcomes.